Marketing-authorisation holder
Pari Pharma Gmbh
10 medicines in 4 countries, as authorisation holder.
Group structure
Part of
PARIPharmaceutical groupOther companies in the group
Spain1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
10 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| COLFINAIRPolvere per soluzione per nebulizzatore | Colistin | Italy | Authorised | |
| COLFINAIR 1 MILLON DE UI POLVO PARA SOLUCION PARA INHALACION POR NEBULIZADOR1 - · Polvo para solución para inhalación por nebulizador | Colistin | Spain | Marketed | 2014 |
| COLFINAIR 2 MILLONES DE UI POLVO PARA SOLUCION PARA INHALACION POR NEBULIZADOR2 - · Polvo para solución para inhalación por nebulizador | Colistin | Spain | Marketed | 2014 |
| ColiFin PARI 1.000.000 IE, poeder voor verneveloplossingPoeder voor verneveloplossing | Colistin | Netherlands | Authorised | 2010 |
| ColiFin PARI 2.000.000 IE, poeder voor verneveloplossingPoeder voor verneveloplossing | Colistin | Netherlands | Authorised | 2010 |
| VANTOBRASoluzione per nebulizzatore | Tobramycin | Italy | Authorised | |
| VANTOBRA 170 MG SOLUCION PARA INHALACION POR NEBULIZADOR170 mg · Solución para inhalación por nebulizador | Tobramycin | Spain | Marketed | 2020 |
| Vantobra 170 mg, verneveloplossingVerneveloplossing | Tobramycin | Netherlands | Authorised | 2019 |
| Vantobra (previously Tobramycin PARI) | Tobramycin | EU (EMA) | Authorised | 2019 |
| Vantobra | Tobramycin | EU (EMA) | Withdrawn | 2015 |